Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016 Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …
News
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016 Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016 Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …
Feature
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016 Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …
News
Roche building

Roche presents new data for advanced bladder cancer immunotherapy

January 8, 2016 Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

Roche has announced updated results from a pivotal Phase II study, showing its investigational cancer immunotherapy atezolizumab extended median progression …
News
Novartis image

Novartis and Qualcomm to develop smart inhaler technology for COPD

January 8, 2016 Manufacturing and Production, Medical Communications COPD, Novartis, Qualcomm Life, breezhaler, digital inhaler, qualcomm

Novartis has enlisted Qualcomm life to help the pharma giant develop the ‘next generation’ of its Breezhaler device for patients …
News
victoria_photo_feb_14

New head for AI drug discovery firm Molplex

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Molplex, Victoria Camargo

The artificial intelligence drug discovery company Molplex has appointed Victoria Camargo as its new chief executive. Camargo replaces the co-founder …
Appointment
HIV infected cell

ViiV and Janssen to test new HIV regimen in Phase III trial

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine

Janssen has formalised its collaboration with ViiV Healthcare on the Phase III development and commercialisation of a two-drug regimen to …
News
dr_paolo_paoletti

PsiOxus Therapeutics appoints Dr Paolo Paoletti as chairman of the board

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …
Appointment
ian_green

Terrence Higgins Trust announces new CEO

January 6, 2016 Medical Communications AIDS, HIV, Terrance Higgins Trust

Leading UK-based HIV and sexual health charity The Terrence Higgins Trust has announced the appointment of Ian Green as the …
Appointment
howard_schiller_valeant

Valeant names interim CEO in Pearson’s absence

January 6, 2016 Medical Communications, Sales and Marketing Valeant

Valeant has named company director Howard Schiller as interim chief executive officer to serve while full-time boss Michael Pearson is …
Appointment
david_pyott

BioMarin elects former Allergan CEO to board

January 5, 2016 Medical Communications, Research and Development, Sales and Marketing

BioMarin Pharmaceutical has announced the election of former Allergan chief executive, David Pyott, to the company’s board of directors. Pyott served …
Appointment
redx

Former Merck R&D expert joins RedX Pharma board

January 4, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RedX Pharma

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …
Appointment
2016

Seven pharma trends for 2016

December 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2016?Pricing pressures
Feature
landing-hero-images1

ViiV Healthcare to acquire Bristol-Myers Squibb’s HIV pipeline drugs

December 18, 2015 Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, HIV, ViiV, ViiV Healthcare

Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026